Topical formulations for treating skin conditions

US9642912B2 · kind B2 · utility

Assignee

• CRESCITA THERAPEUTICS INC. · CA

Inventors

• Edward T. Kisak · San Diego, US
• John M. Newsam · Village of La Jolla, US
• Dominic King-Smith · San Diego, US
• Pankaj Karande · Troy, US
• Samir Mitragotri · Goleta, US
• Wade Hull · Kaysville, US
• Ngoc Truc-Chi Vo · Longueuil, CA

Key dates

• Filing date: Dec 22, 2014
• Grant date: May 9, 2017
• Expiry date: Jul 14, 2035

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61F2007/0261
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure is drawn to topical formulations and related methods. In one embodiment, a topical formulation is provided that includes at least one corticosteroid, a first compound, and a second compound. The first compound and second compound are different and each is selected from the group consisting of N-lauroyl sarcosine, sodium octyl sulfate, methyl laurate, isopropyl myristate, oleic acid, glyceryl oleate, and sodium lauryl sulfoacetate.